
Lenalidomide Capsules By Ambica Pharma
Price: 1098.00 INR / Bottle
(1098.00 + 0% GST)
Get Latest Price
1 Pack Contains :
1
Minimum Pack Size :
50
In Stock
Product Specifications
| Salt Composition | Lenalidomide |
| Dosage Form | Capsule |
| Indication | Multiple myeloma, Myelodysplastic syndromes |
| Enzyme Types | None (Not enzyme-based) |
| Ingredients | Lenalidomide, Excipients |
| Application | Treatment of specific cancers |
| Physical Color/Texture | White to off-white capsules |
| Fermentation Smell | Odorless (no fermentation) |
| Storage Instructions | Store below 25A C, dry place, away from light |
| Shelf Life | 24-36 months |
| Feature | Oral anticancer agent, immunomodulatory |
| Packaging Details | 10X10CAP |
| Main Export Market(s) | Africa |
| Sample Policy | Free samples available with shipping and taxes paid by the buyer |
| Delivery Time | 01 Week |
| Main Domestic Market | All India |
| Supply Ability | 1000 Per Day |
| Payment Terms | Cash in Advance (CID) |
| Certifications | WHO-GMP |
| FOB Port | MUMBAI |
| Sample Available | 1 |
| Unit | 10000 |
| Unit Type | Piece/Pieces |
| Moq | 50 |
| Price | 1098.00 |
| Selling Price | 1098.00 |
| Brand Name | Marrowlin |
| Currency | INR |
| Packsize | 1 |
| Mop | 50 |
| Is Freight Charges | true |
| GSTIN | 0% |
Company Details
This is to introduce ourselves as a professionally managed fast growing Pharmaceutical Company having more than Five Years of Manufacturing and Marketing experience. We are based at Mumbai in the State of Maharashtra. The Company has been accredited with ISO-9001:2008 and manufactures pharmaceutical formulations as per the guidelines of WHO. It is a (GMP Certified) Unit with total quality management and In-house Testing Laboratory. Our success is the result of focusing on our clients top priorities such as quality products, on-time delivery, competitive rates and unparalleled responsiveness. Johnlee manufactures more than 400 plus Pharmaceutical Formulation Products in the form of Tablets, Capsules, Dry syrup, Liquid Orals and Sustained Release Preparations. It is the Company constant and Company will also increasingly focus in high growth potential segments like Vaccines and Biogenetics. These new areas will add significant depth to the existing product pipeline. The proteasome has been validated as an important clinical target in cancer, and Johnlee Pharmaceuticals Pvt. Ltd. is developing next-generation proteasome inhibitors with a high degree of selectivity, with the goal of increasing therapeutic efficacy and reducing side effects.
Business Type
Exporter, Manufacturer, Supplier
Employee Count
20
Establishment
2005
Working Days
To
GST NO
27AGKPJ8183H1ZY
Payment Mode
Cash Advance (CA)
Related Products
Explore Related Categories
More Products From This Seller
Seller Details
GST - 27AGKPJ8183H1ZY
Mumbai, Maharashtra
Director
Mr Vikram K Jain
Address
Office No.22 to 25, 2nd Floor, 72/78, Chapsey Building, Ladwadi, Shamaldas Gandhi Marg, Princess Street, Mumbai, Maharashtra, 400002, India
Report incorrect details


































